Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Mar 18;16(3):e0248649.
doi: 10.1371/journal.pone.0248649. eCollection 2021.

Descriptive analysis of sickle cell patients living in France: The PHEDRE cross-sectional study

Marie Gerardin  1 , Morgane Rousselet  1   2   3 , Marie-Laure Couec  4 , Agathe Masseau  5 , Marylène Guerlais  1 , Nicolas Authier  6 , Sylvie Deheul  7 , Anne Roussin  8 , Joelle Micallef  9 , Samira Djezzar  10 ; French Addictovigilance Network (FAN); Fanny Feuillet  3   11 , Pascale Jolliet  1   3 , Caroline Victorri-Vigneau  1   3
Affiliations
Observational Study

Descriptive analysis of sickle cell patients living in France: The PHEDRE cross-sectional study

Marie Gerardin et al. PLoS One. .

Abstract

Background: Sickle cell disease (SCD) induces chronic haemolytic anaemia and intermittent vaso-occlusion that results in tissue ischaemia causing acute, severe pain episodes that can lead to frequent hospitalizations. These consequences can have repercussions on family, social, school and/or professional life. Here, we present some of the results of the PHEDRE study (Pharmacodépendance Et DREpanocytose-drug dependence and sickle-cell disease), which is the largest study of patients with SCD in France. This paper intends to describe characteristics of the French SCD population. We also aimed to assess the impact of the disease on the lives of patients using objective and subjective variables.

Methods: The PHEDRE study was a national multicentric observational study. Adults, adolescents and children with a confirmed SCD diagnosis were included in the study by their referring doctor. Then, they were interviewed by phone about their socioeconomic status, about the impact of the disease on their lives and about their analgesic and psychoactive drug use.

Results: The study population consisted of 872 patients (28% were minors). Seventy-two percent of adults were active, and all minors were in school. Many patients presented criteria of severe SCD. Seventy-five percent were homozygous SS, 15% were double heterozygotes SC and 8% were heterozygotes Sβthal, 87% received specific treatment, 58% were hospitalized at least once for vaso-occlusive crisis in the past 12 months, and the number of analgesic drugs taken averaged 3.8. Seventy-five percent of patients reported academic or professional consequences related to their SCD, and 52% reported social consequences.

Conclusions: The impact of SCD on patients' lives can be significant, nevertheless their social integration seems to be maintained. We highlighted respect of recommendations regarding analgesic treatments and only a few patients used tobacco, alcohol or cannabis.

Trial registration: Clinical Trials, NCT02580565; https://clinicaltrials.gov/ Registered 16 October 2015.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Age distribution.
Fig 2
Fig 2. Analgesic drugs used at home.
See this image and copyright information in PMC

References

    1. Saraf SL, Molokie RE, Nouraie M, Sable CA, Luchtman-Jones L, Ensing GJ, et al.. Differences in the clinical and genotypic presentation of sickle cell disease around the world. Paediatr Respir Rev. 2014. March 1;15(1):4–12. 10.1016/j.prrv.2013.11.003 - DOI - PMC - PubMed
    1. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet Lond Engl. 2010. December 11;376(9757):2018–31. - PubMed
    1. Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M, et al.. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet Lond Engl. 2013. January 12;381(9861):142–51. 10.1016/S0140-6736(12)61229-X - DOI - PMC - PubMed
    1. Little I, Vinogradova Y, Orton E, Kai J, Qureshi N. Venous thromboembolism in adults screened for sickle cell trait: a population-based cohort study with nested case–control analysis. BMJ Open. 2017. March;7(3):e012665. 10.1136/bmjopen-2016-012665 - DOI - PMC - PubMed
    1. Habibi A, Arlet J-B, Stankovic K, Gellen-Dautremer J, Ribeil J-A, Bartolucci P, et al.. [French guidelines for the management of adult sickle cell disease: 2015 update]. Rev Med Interne. 2015. May 11;36(5 Suppl 1):5S3–84. 10.1016/S0248-8663(15)60002-9 - DOI - PubMed

Publication types

MeSH terms

Associated data